| Typicality: | 0.444 |
| Saliency: | 0.455 |
| from an ebola protein | 3 | other |
| in germany | 2 | location |
| to help prevent people | 2 | purpose |
| vaccine → be developed by → glaxosmithkline | 32 |
| vaccine → be manufactured by → glaxosmithkline | 20 |
| vaccine → be produced by → glaxosmithkline | 16 |
| vaccine → be made by → glaxosmithkline | 11 |
| vaccine → made by → glaxosmithkline | 3 |
| vaccine → developed by → british drugmaker glaxosmithkline | 3 |
| negative | neutral | positive |
| 0.129 | 0.683 | 0.189 |
| Raw frequency | 85 |
| Normalized frequency | 0.455 |
| Modifier score | 0.500 |
| Perplexity | 16.469 |